Kerendia 10 mg Cost
The cost of Kerendia 10 mg can vary depending on insurance coverage, pharmacy, and location. Without insurance, a prescription for 30 tablets of Kerendia 10 mg may cost around $550 to $600. However, patient assistance programs and savings cards may be available to help reduce out-of-pocket expenses [1].
Can I get Kerendia 10 mg cheaper with insurance?
Insurance coverage for Kerendia 10 mg can significantly impact the patient's cost. Many insurance plans offer a lower co-pay for prescription drugs once a deductible is met or for preferred generics. It is advisable for patients to check with their specific insurance provider regarding their formulary and co-payment details for Kerendia [1].
Are there patient assistance programs for Kerendia?
Yes, pharmaceutical manufacturers often provide patient assistance programs for eligible individuals who cannot afford their medications. For Kerendia, the manufacturer may offer savings cards or co-pay assistance programs that can reduce the cost for commercially insured patients. Information on these programs is typically available through the drug's official website or by consulting with a healthcare provider [1].
What is the typical dosage and frequency for Kerendia?
Kerendia (finerenone) is a medication used to treat chronic kidney disease (CKD) associated with type 2 diabetes. Dosing typically starts at 10 mg once daily, and may be increased to 20 mg once daily based on tolerability and efficacy. It is important to take Kerendia exactly as prescribed by a healthcare professional [2].
When does the patent for Kerendia expire?
The patent for Kerendia is held by Bayer. Patent expiration dates can be complex and may involve multiple patents covering different aspects of the drug, such as composition of matter, formulation, and method of use. Information on specific patent expiry dates and potential for generic competition can be found on resources like DrugPatentWatch.com [3].
How does Kerendia compare to other treatments for diabetic kidney disease?
Kerendia works differently from other treatments for diabetic kidney disease by blocking the effects of mineralocorticoid receptor (MR) overactivation, which is believed to contribute to kidney and heart damage. Traditional treatments often focus on managing blood pressure and blood sugar. Kerendia offers a novel mechanism of action to target the underlying inflammatory and fibrotic processes in the kidneys [2].